Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (30.523)

81

Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2019

von Chen, L. | Zhou, L. | Wang, C. | +9

82

Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer : a case report and review of the literature

enthalten in: BMC cancer | 2019

von Hoshina, H. | Takei, H.

83

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol : a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial

enthalten in: BMJ open | 2019

von Jones, A. | Muller, P. | Dore, C. | +6

84

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland

enthalten in: Swiss medical weekly | 2019

von Bhadhuri, A. | Insinga, R. | Guggisberg, P. | +2

85

Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment

enthalten in: Annals of the rheumatic diseases | 2019

von Lee, Y.

CommentOn: Ann Rheum Dis. 2018 Dec;77(12):1720-1729. - PMID 30279267

86

Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option

enthalten in: Anales de pediatria | 2019

von Cubiles Arillo, Z. | Núñez Cuadros, E. | Martínez Rivera, V. | +2

87

fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification

enthalten in: International journal of cancer | 2019

von Takegawa, N. | Tsurutani, J. | Kawakami, H. | +8

88

Low frequency of positive antithyroid antibodies is observed in patients with thyroid dysfunction related to immune check point inhibitors

enthalten in: Journal of endocrinological investigation | 2019

von Mazarico, I. | Capel, I. | Giménez-Palop, O. | +8

89

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis : An Argentinean Perspective

enthalten in: Value in health regional issues | 2019

von Aiello, E. | Bianculli, P. | Bhattacharyya, D. | +2

90

Cost per response for guselkumab versus adalimumab in the United States using data from a head-to-head trial in moderate-to-severe plaque psoriasis

enthalten in: Journal of medical economics | 2019

von Teeple, A. | Muser, E.